| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.009 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |